Clinical and histopathologic correlates of 11C-alpha-methyl-L- tryptophan (AMT) PET abnormalities in children with intractable epilepsy

Epilepsia

Volumn 52, Issue 9, 2011, Pages 1692-1698

  Chugani, Harry T ^a   Kumar, Ajay ^a   Kupsky, William ^a   Asano, Eishi ^a   Sood, Sandeep ^a   Juhász, Csaba ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

2 18F fluoro 2 deoxy D glucose (FDG) positron emission tomography; Alpha methyl tryptophan; Cortical dysplasia; Epilepsy surgery; Malformation of cortical development

Indexed keywords

ALPHA METHYL LEVO TRYPTOPHAN C 11; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BRAIN SCINTISCANNING; BRAIN SURGERY; CHILD; CLINICAL ARTICLE; CORTICAL DYSPLASIA; DISEASE SEVERITY; FEMALE; GLIOSIS; HETEROTOPIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTRACTABLE EPILEPSY; MALE; MICROGYRIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERIVENTRICULAR HETEROTOPIA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

BRAIN MAPPING; CARBON RADIOISOTOPES; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; STATISTICS AS TOPIC; TRYPTOPHAN;

EID: 80052522265     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03103.x     Document Type: Article

References (41)

1. Asano E, Chugani DC, Muzik O, Shen C, Juhasz C, Janisse J, Ager J, Canady A, Shah JR, Shah AK, Watson C, Chugani HT,. (2000) Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54: 1976-1984. (Pubitemid 30327123)
2. Boer K, Spliet WG, van Rijen PC, Redeker S, Troost D, Aronica E,. (2006) Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 173: 188-195.
3. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E,. (2008) Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78: 7-21. (Pubitemid 350296774)
4. Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F,. (1995) Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J Neurochem 65: 1176-1183.
5. Chugani HT, Chugani DC,. (2005) Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr 5: 201-206.
6. Chugani DC, Muzik O,. (2000) Alpha[C-11]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 20: 2-9. (Pubitemid 30019823)
7. Chugani DC, Chugani HT, Muzik O, Shah JR, Shah AK, Canady A, Mangner TJ, Chakraborty PK,. (1998a) Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44: 858-866. (Pubitemid 28558246)
8. Chugani DC, Muzik O, Chakraborty P, Mangner T, Chugani HT,. (1998b) Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L- tryptophan. Synapse 28: 33-43. (Pubitemid 128770601)
9. Diksic M, Nagahiro S, Chaly T, Sourkes TL, Yamamoto YL, Feindel W,. (1991) Serotonin synthesis rate measured in living dog brain by positron emission tomography. J Neurochem 56: 153-162. (Pubitemid 21901943)
10. Engel JJ, Van Ness PC, Rasmussen TB, Ojemann LM,. (1993) Outcome with respect to epileptic seizures. In, Engel JJ, (Ed.) Surgical treatment of the epilepsies. Raven, New York, pp. 609-622.
11. Fauser S, Schulze-Bonhage A, Honegger J, Carmona H, Huppertz HJ, Pantazis G, Rona S, Bast T, Strobl K, Steinhoff BJ, Korinthenberg R, Rating D, Volk B, Zentner J,. (2004) Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 127: 2406-2418. (Pubitemid 39472968)
12. Fedi M, Reutens D, Okazawa H, Andermann F, Boling W, Dubeau F, White C, Nakai A, Gross DW, Andermann E, Diksic M,. (2001) Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 57: 1629-1636. (Pubitemid 33055481)
13. Feldblum S, Rougier A, Loiseau H, Loiseau P, Cohadon F, Morselli PL, Lloyd KG,. (1988) Quinolinic acid phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia 29: 523-529.
14. Haber R, Bessette D, Hulihan-Giblin B, Durcan MJ, Goldman D,. (1993) Identification of tryptophan 2,3-dioxygenase RNA in rodent brain. J Neurochem 60: 1159-1162. (Pubitemid 23066742)
15. Hery F, Chouvet G, Kan JP, Pujol JF, Glowinski J,. (1977) Daily variations of various parameters of serotonin metabolism in the rat brain. II. Circadian variations in serum and cerebral tryptophan levels: lack of correlation with 5-HT turnover. Brain Res 123: 137-145. (Pubitemid 8051278)
16. Heyes MP, Wyler AR, Devinsky O, Yergey JA, Markey SP, Nadi NS,. (1990) Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia 31: 172-177. (Pubitemid 20115146)
17. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP,. (1996) Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 320 (Pt 2): 595-597. (Pubitemid 26417785)
18. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E,. (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51: 1763-1773.
19. Juhasz C, Chugani DC, Muzik O, Shah A, Asano E, Mangner TJ, Chakraborty PK, Sood S, Chugani HT,. (2003) Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60: 960-968. (Pubitemid 36348928)
20. Juhasz C, Chugani DC, Padhye UN, Muzik O, Shah A, Asano E, Mangner TJ, Chakraborty PK, Sood S, Chugani HT,. (2004) Evaluation with alpha-[11C]methyl-L- tryptophan positron emission tomography for reoperation after failed epilepsy surgery. Epilepsia 45: 124-130. (Pubitemid 38174118)
21. Kagawa K, Chugani DC, Asano E, Juhasz C, Muzik O, Shah A, Shah J, Sood S, Kupsky WJ, Mangner TJ, Chakraborty PK, Chugani HT,. (2005) Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 20: 429-438. (Pubitemid 40873049)
22. Lapin IP,. (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42: 37-43. (Pubitemid 8271036)
23. Lehrmann E, Guidetti P, Love A, Williamson J, Bertram EH, Schwarcz R,. (2008) Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice. Epilepsia 49 (Suppl. 2): 13-23. (Pubitemid 351143762)
24. Muzik O, Chugani DC, Shen C, Chugani HT,. (1998) Noninvasive imaging of serotonin synthesis rate using PET and α-methyltryptophan in autistic children. In, Carson RE, Daube-Witherspoon ME, Herscovitch P, (Eds) Quantitative functional brain imaging with positron emission tomography. Academic Press, San Diego, pp. 201-206.
25. Nakano K, Takahashi S, Mizobuchi M, Kuroda T, Masuda K, Kitoh J,. (1993) High levels of quinolinic acid in brain of epilepsy-prone E1 mice. Brain Res 619: 195-198. (Pubitemid 23214322)
26. Nemeth H, Robotka H, Kis Z, Rozsa E, Janaky T, Somlai C, Marosi M, Farkas T, Toldi J, Vecsei L,. (2004) Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology 47: 916-925. (Pubitemid 39440985)
27. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV,. (2004) Terminology and classification of the cortical dysplasias. Neurology 62: S2-S8. (Pubitemid 38419835)
28. Perkins MN, Stone TW,. (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247: 184-187. (Pubitemid 12028646)
29. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A,. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160. (Pubitemid 350180489)
30. Saito K, Crowley JS, Markey SP, Heyes MP,. (1993) A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem 268: 15496-15503. (Pubitemid 23222041)
31. Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H,. (2010) Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol 69: 838-849.
32. Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, Cardinale F, Cossu M, Ferrario A, Galli C, Bramerio M, Citterio A, Spreafico R,. (2002) Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125: 1719-1732.
33. Tassi L, Garbelli R, Colombo N, Bramerio M, Lo Russo G, Deleo F, Milesi G, Spreafico R,. (2010) Type I focal cortical dysplasia: surgical outcome is related to histopathology. Epileptic Disord 12: 181-191.
34. Taylor MW, Feng GS,. (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516-2522. (Pubitemid 21905800)
35. Vezzani A, Ungerstedt U, French ED, Schwarcz R,. (1985) In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures. J Neurochem 45: 335-344. (Pubitemid 15233929)
36. Vezzani A, Stasi MA, Wu HQ, Castiglioni M, Weckermann B, Samanin R,. (1989) Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability. Exp Neurol 106: 90-98. (Pubitemid 19246455)
37. Vezzani A, Balosso S, Ravizza T,. (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797-803.
38. Wakamoto H, Chugani DC, Juhasz C, Muzik O, Kupsky WJ, Chugani HT,. (2008) Alpha-methyl-l-tryptophan positron emission tomography in epilepsy with cortical developmental malformations. Pediatr Neurol 39: 181-188.
39. Wu HQ, Lee SC, Scharfman HE, Schwarcz R,. (2002) L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat. Exp Neurol 177: 222-232. (Pubitemid 35356835)
40. Yamazaki F, Kuroiwa T, Takikawa O, Kido R,. (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 230: 635-638. (Pubitemid 16236320)
41. Zhang DX, Williamson JM, Wu HQ, Schwarcz R, Bertram EH,. (2005) In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls. Epilepsia 46: 1708-1715. (Pubitemid 44921955)